Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Minden

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Preferential eradication of acute myelogenous leukemia stem cells by fenretinideHui Zhang, Jian-Qing Mi, Hai Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Cancer Cell|January 8, 2019
Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor PropagationQingfei Jiang, Jane Isquith, Maria Anna Zipeto, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
British Journal of Haematology|May 13, 2020
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapyHassan Sibai, Ruiqi Chen, Xing Liu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCTDonna Zhe Sian Eng, Fatima Khadadah, Maria Agustina Perusini, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood|May 23, 2008
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemiaGuillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Preferential eradication of acute myelogenous leukemia stem cells by fenretinideHui Zhang, Jian-Qing Mi, Hai Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Cancer Cell|January 8, 2019
Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor PropagationQingfei Jiang, Jane Isquith, Maria Anna Zipeto, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
British Journal of Haematology|May 13, 2020
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapyHassan Sibai, Ruiqi Chen, Xing Liu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCTDonna Zhe Sian Eng, Fatima Khadadah, Maria Agustina Perusini, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood|May 23, 2008
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemiaGuillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Pageof 6